Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines)
Florian Slimano, Amandine Baudouin, Jérémie Zerbit, A. Toulemonde-Deldicque, Audrey Thomas‐Schoemann, R. Chevrier, Mikaël Daouphars, Isabelle Madelaine, Bertrand Pourroy, Jean‐François Tournamille, A. Astier, Florence Ranchon, Jean‐Louis Cazin, Christophe Bardin, Catherine Rioufol
Topics & Concepts
MedicinePandemicCancerPharmacyIntensive care medicineDiseasePolypharmacyAdverse effectDrugCoronavirus disease 2019 (COVID-19)OncologyInternal medicinePharmacologyFamily medicineInfectious disease (medical specialty)COVID-19 and healthcare impactsEconomic and Financial Impacts of CancerCOVID-19 Clinical Research Studies